Meeder Asset Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
NTCM
CCM
Meeder Asset Management's IRMD Position: Q3 2025 in Review
Meeder Asset Management sold out of iRadimed (IRMD) in Q3 2025, closing a stake of 453 shares — an estimated $27.1K sold.
Meeder Asset Management first reported a position in IRMD in Q4 2016 and held it in 8 quarters. The position peaked at $27.1K in Q2 2025. 185 funds tracked by Wall St. Rank hold IRMD as of Q3 2025.
- Meeder Asset Management reported no remaining iRadimed position as of Q3 2025 after selling out during the quarter.
- Meeder Asset Management sold 453 iRadimed shares in Q3 2025, an estimated $27.1K.
- Meeder Asset Management first reported a position in iRadimed in Q4 2016 and held it in 8 quarters.
- Meeder Asset Management's iRadimed position peaked at $27.1K in Q2 2025.
- 185 funds tracked by Wall St. Rank held iRadimed as of Q3 2025.
Based on Meeder Asset Management's 13F filing for Q3 2025, filed 24 Oct 2025.